- Product will be a Prasco “Authorized Generic” mirtazapine Orally Disintegrating Tablets, and Prasco is the only generic company to offer all three strengths (15, 30, and 45 mg) generically
- Prasco’s product is the only generic for Remeron SolTab® Orally Disintegrating Tablets in the 45 mg strength

Cincinnati, Ohio, October 6, 2004—Prasco Laboratories, a privately-held pharmaceutical company located in Cincinnati, Ohio, announced today it began shipping its antidepressant Mirtazapine Orally Disintegrating Tablets on October 1, 2004. Mirtazapine Orally Disintegrating Tablets is a Prasco “Authorized Generic” for the AB-rated brand Remeron SolTab® Orally Disintegrating Tablets from Organon. Prasco has received the rights to market the 15, 30 and 45 mg strengths. Prasco is the only US generic marketer of the 45 mg strength Mirtazapine Orally Disintegrating Tablets.

“We are pleased to provide pharmacists and consumers with an important multi-source option as the second supplier of 15 and 30 mg strengths and the only generic supplier of the 45 mg strength,” said Prasco Chief Executive Officer E. Thomas Arington. “With the 45 mg strength, Prasco is the first company to offer the complete generic Mirtazapine Orally Disintegrating Tablets line—every dosage strength offered by the brand product.”

Prasco’s Authorized Generic Mirtazapine Orally Disintegrating Tablets
Mirtazapine Orally Disintegrating Tablets is the latest product in Prasco’s rapidly growing line of “Authorized Generics”, bringing consumers value through at brand quality, generic prices. Mirtazapine Orally Disintegrating Tablets, manufactured for Prasco by CIMA Labs Inc., will have the same orange taste and mouth-feel as the brand product.

“One advantage that distinguishes our product is that patients will have the identical experience taking Prasco’s Mirtazapine Orally Disintegrating Tablets that they would have in taking Remeron SolTab® Orally Disintegrating Tablets. We believe that having the same flavor and dissolving rate as the brand product is very important to consumers, giving them confidence in the generic product by providing the same experience they are accustomed to with the brand,” said Arington.

About Prasco
Founded by Arington in 2002, Prasco’s mission is to provide both quality products and significant cost-savings to the consumer. Prasco is a leading multi-source marketing and distribution company that utilizes a versatile, horizontally-integrated business approach to efficiently link manufacturers to retailers to consumers. Prasco combines its intellectual property with the special capabilities of selected partners to realize opportunities and benefit consumers by finding and filling unmet needs within the pharmaceutical marketplace.

Prasco’s goal is to lead the field in bringing to consumers Prasco Authorized Generics, which are brand products sold under the Prasco private label. Prasco’s executive team has extensive experience working within both the brand and generic industries. A centerpiece of the company’s corporate capabilities is its sales/marketing and business development teams. Prasco’s product line is currently sold through the major distribution channels including chains, independent pharmacies, distributors, wholesalers, and managed care providers.

The company operates from a 54,000 sq. ft. administrative office and warehouse facility and has complete control over product distribution management systems—including DEA-approved facilities for Schedule II-V controlled drug products.

About Organon
Organon – headquartered in Roseland, NJ, USA – creates and markets prescription medicines that improve the health and quality of human life. Through a combination of independent growth and business partnerships Organon strives to become or remain one of the leading pharmaceutical companies in each of its core therapeutic fields: reproductive medicine, psychiatry and anesthesia. Organon products are sold in over 100 countries, of which more than 60 have an Organon subsidiary. Organon is the human health care business unit of Akzo Nobel NV.

Remeron SolTab is a registered trademark of Organon

###

CONTACT:
Jeff Zurcher, Advisor to the Chairman, Communications
Prasco Laboratories
513-618-3333
web site: www.prasco.com